|
1
|
Reid BM, Permuth JB and Sellers TA:
Epidemiology of ovarian cancer: A review. Cancer Biol Med. 14:9–32.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in china. CA
Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang L, Luo M, Yang H, Zhu S, Cheng X and
Qing C: Next-generation sequencing-based genomic profiling analysis
reveals novel mutations for clinical diagnosis in chinese primary
epithelial ovarian cancer patients. J Ovarian Res. 12:192019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carlson LE, Angen M, Cullum J, Goodey E,
Koopmans J, Lamont L, MacRae JH, Martin M, Pelletier G and Robinson
J: High levels of untreated distress and fatigue in cancer
patients. Br J Cancer. 90:2297–2304. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sellick SM and Crooks DL: Depression and
cancer: An appraisal of the literature for prevalence, detection,
and practice guideline development for psychological interventions.
Psychooncology. 8:315–333. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zabora J, BrintzenhofeSzoc K, Curbow B,
Hooker C and Piantadosi S: The prevalence of psychological distress
by cancer site. Psychooncology. 10:19–28. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Greimel E, Thiel I, Peintinger F, Cegnar I
and Pongratz E: Prospective assessment of quality of life of female
cancer patients. Gynecol Oncol. 85:140–147. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lutgendorf SK, Slavich GM, Degeest K,
Goodheart M, Bender D, Thaker PH, Penedo F, Zimmerman B, Lucci J
III, Mendez L, et al: Non-cancer life stressors contribute to
impaired quality of life in ovarian cancer patients. Gynecol Oncol.
131:667–673. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Watts S, Prescott P, Mason J, McLeod N and
Lewith G: Depression and anxiety in ovarian cancer: A systematic
review and meta-analysis of prevalence rates. BMJ Open.
5:e0076182015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang T, Poole EM, Okereke OI, Kubzansky
LD, Eliassen AH, Sood AK, Wang M and Tworoger SS: Depression and
risk of epithelial ovarian cancer: Results from two large
prospective cohort studies. Gynecol Oncol. 139:481–486. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mielcarek P, Nowicka-Sauer K and Kozaka J:
Anxiety and depression in patients with advanced ovarian cancer: A
prospective study. J Psychosom Obstet Gynaecol. 37:57–67. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu C, Zhao Y, Liu Y, Yang X, Yan M, Min Y,
Pan Z, Qiu S, Xia S, Yu J, et al: Identifying miRNA-mRNA regulation
network of major depressive disorder in ovarian cancer patients.
Oncol Lett. 16:5375–5382. 2018.PubMed/NCBI
|
|
14
|
Rahman MR, Islam T, Al-Mamun MA, Zaman T,
Karim MR and Moni MA: The influence of depression on ovarian
cancer: Discovering molecular pathways that identify novel
biomarkers and therapeutic targets. Informatics Med Unlocked.
16:1002072019. View Article : Google Scholar
|
|
15
|
Watson M, Haviland JS, Greer S, Davidson J
and Bliss JM: Influence of psychological response on survival in
breast cancer: A population-based cohort study. Lancet.
354:1331–1336. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
DiMatteo MR, Lepper HS and Croghan TW:
Depression is a risk factor for noncompliance with medical
treatment: Meta-analysis of the effects of anxiety and depression
on patient adherence. Arch Intern Med. 160:2101–2107. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yamamoto T, Yanagimoto H, Satoi S,
Toyokawa H, Hirooka S, Yamaki S, Yui R, Yamao J, Kim S and Kwon AH:
Circulating CD4+CD25+ regulatory T cells in patients with
pancreatic cancer. Pancreas. 41:409–415. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lutgendorf SK, DeGeest K, Sung CY, Arevalo
JM, Penedo F, Lucci J III, Goodheart M, Lubaroff D, Farley DM, Sood
AK and Cole SW: Depression, social support, and beta-adrenergic
transcription control in human ovarian cancer. Brain Behav Immun.
23:176–183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cole SW, Arevalo JMG, Takahashi R, Sloan
EK, Lutgendorf SK, Sood AK, Sheridan JF and Seeman TE:
Computational identification of gene-social environment interaction
at the human IL6 locus. Proc Natl Acad Sci. 107:5681–5686. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang J, Vasaikar S, Shi Z, Greer M and
Zhang B: WebGestalt 2017: A more comprehensive, powerful, flexible
and interactive gene set enrichment analysis toolkit. Nucleic Acids
Res. 45:W130–W137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen J, Bardes EE, Aronow BJ and Jegga AG:
ToppGene Suite for gene list enrichment analysis and candidate gene
prioritization. Nucleic Acids Res. 37:W305–W311. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:D991–D995. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Radloff LS: The CES-D scale: A self-report
depression scale for research in the general population. Appl
Psychol Meas. 1:385–401. 1977. View Article : Google Scholar
|
|
24
|
Cutroa CE and Rusell DW: The provisions of
social relationships and adaptation to stress. Adv Pers
Relationships. 1:37–67. 1987.
|
|
25
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shannon P, Markiel A, Owen O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Scardoni G, Petterlini M and Laudanna C:
Analyzing biological network parameters with centiScaPe.
Bioinformatics. 25:2857–2859. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fox R: A view from the web. J R Soc Med.
90:4731997. View Article : Google Scholar
|
|
31
|
Jia P, Kao CF, Kuo PH and Zhao Z: A
comprehensive network and pathway analysis of candidate genes in
major depressive disorder. BMC Syst Biol. 5 (Suppl 3):S122011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu Y, Pan Z, Hu Y, Zhang L and Wang J:
Network and pathway-based analyses of genes associated with
parkinson's disease. Mol Neurobiol. 54:4452–4465. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Niwattanakul S, Singthongchai J, Naenudorn
E and Wanapu S: Using of jaccard coefficient for keywords
similarity. Proc Int Multiconference Eng Comput Sci. 1:13–15.
2013.
|
|
34
|
Mizuno S, Yamaguchi T, Fukushima A,
Matsuyama Y and Ohashi Y: Overlap coefficient for assessing the
similarity of pharmacokinetic data between ethnically different
populations. Clin Trials. 2:174–181. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gyorffy B, Lánczky A and Szállási Z:
Implementing an online tool for genome-wide validation of
survival-associated biomarkers in ovarian-cancer using microarray
data from 1287 patients. Endocr Relat Cancer. 19:197–208. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cancer Genome Atlas Research Network, ;
Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA,
Ellrott K, Shmulevich I, Sander C and Stuart JM: The cancer genome
atlas pan-cancer analysis project. Nat Genet. 45:1113–1120. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Denkert C, Budczies J, Darb-Esfahani S,
Györffy B, Sehouli J, Könsgen D, Zeillinger R, Weichert W, Noske A,
Buckendahl AC, et al: A prognostic gene expression index in ovarian
cancer-validation across different independent data sets. J Pathol.
218:273–280. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ahmed AA, Mills AD, Ibrahim AE, Temple J,
Blenkiron C, Vias M, Massie CE, Iyer NG, McGeoch A, Crawford R, et
al: The extracellular matrix protein TGFBI induces microtubule
stabilization and sensitizes ovarian cancers to paclitaxel. Cancer
Cell. 12:514–527. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mok SC, Bonome T, Vathipadiekal V, Bell A,
Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, et al: A
gene signature predictive for outcome in advanced ovarian cancer
identifies a survival factor: Microfibril-associated glycoprotein
2. Cancer Cell. 16:521–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Konstantinopoulos PA, Spentzos D, Karlan
BY, Taniguchi T, Fountzilas E, Francoeur N, Levine DA and Cannistra
SA: Gene expression profile of BRCAness that correlates with
responsiveness to chemotherapy and with outcome in patients with
epithelial ovarian cancer. J Clin Oncol. 28:3555–3561. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Marchion DC, Cottrill HM, Xiong Y, Chen N,
Bicaku E, Fulp WJ, Bansal N, Chon HS, Stickles XB, Kamath SG, et
al: BAD phosphorylation determines ovarian cancer chemosensitivity
and patient survival. Clin Cancer Res. 17:6356–6366. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Gentric G, Kieffer Y, Mieulet V, Goundiam
O, Bonneau C, Nemati F, Hurbain I, Raposo G, Popova T, Stern MH, et
al: PML-regulated mitochondrial metabolism enhances
chemosensitivity in human ovarian cancers. Cell Metab. 29:156–173.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mateescu B, Batista L, Cardon M, Gruosso
T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P,
Sastre-Garau X and Mechta-Grigoriou F: MiR-141 and miR-200a act on
ovarian tumorigenesis by controlling oxidative stress response. Nat
Med. 17:1627–1635. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bonome T, Levine DA, Shih J, Randonovich
M, Pise-Masison CA, Bogomolniy F, Ozbun L, Brady J, Barrett JC,
Boyd J and Birrer MJ: A gene signature predicting for survival in
suboptimally debulked patients with ovarian cancer. Cancer Res.
68:5478–5486. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Vathipadiekal V, Wang V, Wei W, Waldron L,
Drapkin R, Gillette M, Skates S and Birrer M: Creation of a human
secretome: A novel composite library of human secreted proteins:
Validation using ovarian cancer gene expression data and a virtual
secretome array. Clin Cancer Res. 21:4960–4969. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
King ER, Tung CS, Tsang YT, Zu Z, Lok GT,
Deavers MT, Malpica A, Wolf JK, Lu KH, Birrer MJ, et al: The
anterior gradient homolog 3 (AGR3) gene is associated with
differentiation and survival in ovarian cancer. Am J Surg Pathol.
35:904–912. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Ferriss JS, Kim Y, Duska L, Birrer M,
Levine DA, Moskaluk C, Theodorescu D and Lee JK: Multi-gene
expression predictors of single drug responses to adjuvant
chemotherapy in ovarian carcinoma: Predicting platinum resistance.
PLoS One. 7:e305502012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bild AH, Yao G, Chang JT, Wang Q, Potti A,
Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, et al:
Oncogenic pathway signatures in human cancers as a guide to
targeted therapies. Nature. 439:353–357. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Koti M, Gooding RJ, Nuin P, Haslehurst A,
Crane C, Weberpals J, Childs T, Bryson P, Dharsee M and Evans K:
Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks
associated with chemotherapy resistance and treatment response in
high-grade serous epithelial ovarian cancer. BMC Cancer.
13:5492013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Lisowska KM, Olbryt M, Dudaladava V,
Pamuła-Piłat J, Kujawa K, Grzybowska E, Jarząb M, Student S,
Rzepecka IK, Jarząb B and Kupryjańczyk J: Gene expression analysis
in ovarian cancer-faults and hints from DNA microarray study. Front
Oncol. 4:62014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Uehara Y, Oda K, Ikeda Y, Koso T, Tsuji S,
Yamamoto S, Asada K, Sone K, Kurikawa R, Makii C, et al: Integrated
copy number and expression analysis identifies profiles of
whole-arm chromosomal alterations and subgroups with favorable
outcome in ovarian clear cell carcinomas. PLoS One.
10:e01280662015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tothill RW, Tinker AV, George J, Brown R,
Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro
B, et al: Novel molecular subtypes of serous and endometrioid
ovarian cancer linked to clinical outcome. Clin Cancer Res.
14:5198–5208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. 394–424. 2018.PubMed/NCBI
|
|
54
|
Chaturvedi SK: Psychiatric oncology:
Cancer in mind. Indian J Psychiatry. 54:111–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pasquini M and Biondi M: Depression in
cancer patients: A critical review. Clin Pract Epidemiol Ment
Health. 3:22007. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Prasad SM, Eggener SE, Lipsitz SR, Irwin
MR, Ganz PA and Hu JC: Effect of depression on diagnosis,
treatment, and mortality of men with clinically localized prostate
cancer. J Clin Oncol. 32:2471–2478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Colombo N, Lorusso D and Scollo P: Impact
of recurrence of ovarian cancer on quality of life and outlook for
the future. Int J Gynecol Cancer. 27:1134–1140. 2017. View Article : Google Scholar
|
|
58
|
Leighton SP, Nerurkar L, Krishnadas R,
Johnman C, Graham GJ and Cavanagh J: Chemokines in depression in
health and in inflammatory illness: A systematic review and
meta-analysis. Mol Psychiatry. 23:48–58. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Eyre HA, Air T, Pradhan A, Johnston J,
Lavretsky H, Stuart MJ and Baune BT: A meta-analysis of chemokines
in major depression. Prog Neuropsychopharmacol Biol Psychiatry.
68:1–8. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chen K, Pociask DA, McAleer JP, Chan YR,
Alcorn JF, Kreindler JL, Keyser MR, Shapiro SD, Houghton AM, Kolls
JK and Zheng M: IL-17RA is required for CCL2 expression, macrophage
recruitment, and emphysema in response to cigarette smoke. PLoS
One. 6:e203332011. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Lim SY, Yuzhalin AE, Gordon-Weeks AN and
Muschel RJ: Targeting the CCL2-CCR2 signaling axis in cancer
metastasis. Oncotarget. 7:28697–28710. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Yu T, Guo M, Garza J, Rendon S, Sun X,
Zhang W and Lu XY: Cognitive and neural correlates of
depression-like behaviour in socially defeated mice: An animal
model of depression with cognitive dysfunction. Int J
Neuropsychopharmacol. 14:303–317. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kung JC, Chen TC, Shyu BC, Hsiao S and
Huang AC: Anxiety- and depressive-like responses and c-fos activity
in preproenkephalin knockout mice: Oversensitivity hypothesis of
enkephalin deficit-induced posttraumatic stress disorder. J Biomed
Sci. 17:292010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yokoyama K, Hiyama A, Arai F, Nukaga T,
Sakai D and Mochida J: C-Fos regulation by the MAPK and PKC
pathways in intervertebral disc cells. PLoS One. 8:1–14. 2013.
View Article : Google Scholar
|
|
65
|
Whitmarsh AJ: Regulation of gene
transcription by mitogen-activated protein kinase signaling
pathways. Biochim Biophys Acta. 1773:1285–1298. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Li JK, Nie L, Zhao YP, Zhang YQ, Wang X,
Wang SS, Liu Y, Zhao H and Cheng L: IL-17 mediates inflammatory
reactions via p38/c-Fos and JNK/c-Jun activation in an
AP-1-dependent manner in human nucleus pulposus cells. J Transl
Med. 14:772016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Ma X, Reynolds SL, Baker BJ, Li X,
Benveniste EN and Qin H: IL-17 enhancement of the IL-6 signaling
cascade in astrocytes. J Immunol. 184:4898–4906. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Hayashi KG, Ushizawa K, Hosoe M and
Takahashi T: Differential gene expression of serine protease
inhibitors in bovine ovarian follicle: Possible involvement in
follicular growth and atresia. Reprod Biol Endocrinol. 9:722011.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Lassila M, Fukami K, Jandeleit-Dahm K,
Semple T, Carmeliet P, Cooper ME and Kitching AR: Plasminogen
activator inhibitor-1 production is pathogenetic in experimental
murine diabetic renal disease. Diabetologia. 50:1315–1326. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yamamoto K, Takeshita K, Shimokawa T, Yi
H, Isobe K, Loskutoff DJ and Saito H: Plasminogen activator
inhibitor-1 is a major stress-regulated gene: Implications for
stress-induced thrombosis in aged individuals. Proc Natl Acad Sci.
99:890–895. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Eskandari F, Mistry S, Martinez PE, Torvik
S, Kotila C, Sebring N, Drinkard BE, Levy C, Reynolds JC, Csako G,
et al: Younger, premenopausal women with major depressive disorder
have more abdominal fat and increased serum levels of prothrombotic
factors: Implications for greater cardiovascular risk. Metabolism.
54:918–924. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Lahlou-Laforet K, Alhenc-Gelas M, Pornin
M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY,
Ducimetiere P, Aiach M, et al: Relation of depressive mood to
plasminogen activator inhibitor, tissue plasminogen activator, and
fibrinogen levels in patients with versus without coronary heart
disease. Am J Cardiol. 97:1287–1291. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Tsai SJ, Hong CJ, Liou YJ, Yu YW and Chen
TJ: Plasminogen activator inhibitor-1 gene is associated with major
depression and antidepressant treatment response. Pharmacogenet
Genomics. 18:869–875. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Fang Y, Zhang L, Zeng Z, Lian Y, Jia Y,
Zhu H and Xu Y: Promoter polymorphisms of SERPINE1 are associated
with the antidepressant response to depression in alzheimer's
disease. Neurosci Lett. 516:217–220. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Haslund D, Ryø LB, Seidelin Majidi S, Rose
I, Skipper KA, Fryland T, Bohn AB, Koch C, Thomsen MK, Palarasah Y,
et al: Dominant-negative SERPING1 variants cause intracellular
retention of C1 inhibitor in hereditary angioedema. J Clin Invest.
129:388–405. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Madsen DE, Hansen S, Gram J, Bygum A,
Drouet C and Sidelmann JJ: Presence of C1-inhibitor polymers in a
subset of patients suffering from hereditary angioedema. PLoS One.
9:e1120512014. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lumry WR, Craig T, Zuraw B, Longhurs H,
Baker J, Li HH, Bernstein JA, Anderson J, Riedl MA, Manning ME, et
al: Health-related quality of life with subcutaneous C1-inhibitor
for prevention of attacks of hereditary angioedema. J Allergy Clin
Immunol Pract. 112:1733–1741. 2018. View Article : Google Scholar
|
|
78
|
Fouche AS, Saunders EF and Craig T:
Depression and anxiety in patients with hereditary angioedema. Ann
Allergy Asthma Immunol. 112:371–375. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Varga L, Széplaki G, Laki J, Kocsis A,
Kristóf K, Gál P, Bajtay Z, Wieslander J, Daha MR, Garred P, et al:
Depressed activation of the lectin pathway of complement in
hereditary angioedema. Clin Exp Immunol. 153:68–74. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Ditzen C, Tang N, Jastorff AM, Teplytska
L, Yassouridis A, Maccarrone G, Uhr M, Bronisch T, Miller CA,
Holsboer F and Turck CW: Cerebrospinal fluid biomarkers for major
depression confirm relevance of associated pathophysiology.
Neuropsychopharmacology. 37:1013–1025. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Liu RM: Oxidative stress, plasminogen
activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal.
10:303–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Oh CK, Ariue B, Alban RF, Shaw B and Cho
SH: PAI-1 promotes extracellular matrix deposition in the airways
of a murine Asthma model. Biochem Biophys Res Commun.
294:1155–1160. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Singer M and Jones AM: Bench-to-bedside
review: The role of C1-esterase inhibitor in sepsis and other
critical illnesses. Crit Care. 15:2032011. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Davis AE III, Lu F and Mejia P: C1
inhibitor, a multi-functional serine protease inhibitor. Thromb
Haemost. 104:886–893. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Green TA, Alibhai IN, Unterberg S, Neve
RL, Ghose S, Tamminga CA and Nestler EJ: Induction of activating
transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus
accumbens and their regulation of emotional behavior. J Neurosci.
28:2025–2032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Turner CA, Sharma V, Hagenauer MH,
Chaudhury S, O'Connor AM, Hebda-Bauer EK, Thompson RC, Myers RM,
Bunney WE and Barchas JD: Connective tissue growth factor is a
novel prodepressant. Biol Psychiatry. 84:555–562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Giese-Davis J, Collie K, Rancourt KM, Neri
E, Kraemer HC and Spiegel D: Decrease in depression symptoms is
associated with longer survival in patients with metastatic breast
cancer: A secondary analysis. J Clin Oncol. 29:413–420. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Raison CL and Miller AH: The evolutionary
significance of depression in pathogen host defense (PATHOS-D). Mol
Psychiatry. 18:15–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wojnarowicz P, Gambaro K, de Ladurantaye
M, Quinn MC, Provencher D, Mes-Masson AM and Tonin PN:
Overexpressing the CCL2 chemokine in an epithelial ovarian cancer
cell line results in latency of in vivo tumourigenicity.
Oncogenesis. 1:e272012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Mahner S, Baasch C, Schwarz J, Hein S,
Wölber L, Jänicke F and Milde-Langosch K: C-Fos expression is a
molecular predictor of progression and survival in epithelial
ovarian carcinoma. Br J Cancer. 99:1269–1275. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Andreasen PA, Kjøller L, Christensen L and
Duffy MJ: The urokinase-type plasminogen activator system in cancer
metastasis: A review. Int J cancer. 72:1–22. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Klein RM, Bernstein D, Higgins SP, Higgins
CE and Higgins PJ: SERPINE1 expression discriminates site-specific
metastasis in human melanoma. Exp Dermatol. 21:551–554. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Peng S, Du T, Wu W, Chen X, Lai Y, Zhu D,
Wang Q, Ma X, Lin C, Li Z, et al: Decreased expression of serine
protease inhibitor family G1 (SERPING1) in prostate cancer can help
distinguish high-risk prostate cancer and predicts malignant
progression. Urol Oncol. 36:366.e1–366.e9. 2018. View Article : Google Scholar
|
|
94
|
Mejia P, Diez-Silva M, Kamena F, Lu F,
Fernandes SM, Seeberger PH, Davis AE III and Mitchell JR: Human
C1-inhibitor suppresses malaria parasite invasion and cytoadhesion
via binding to parasite glycosylphosphatidylinositol and host cell
receptors. J Infect Dis. 213:80–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
